3D Medical Imaging Solutions Growing In Affordability In Europe
New analysis from Frost & Sullivan (http://www.medicalimaging.frost.com), European 3D Imaging Markets, finds that the market earned revenues of USD 210.0 million in 2007 and estimates this to reach USD 521.5 million in 2014.
"In the past few years, the 3D imaging market has become one of the highest growth segments in the medical imaging field, and this trend is set to persist as these applications become more affordable and research proves their clinical value," notes Frost & Sullivan Research Analyst Darshana De. "Most of these applications will provide non-invasive alternatives that have the potential to improve standards of care for patients."
3D medical imaging solutions are additional imaging tools that help display images more accurately, displaying internal body structures with a three-dimensional view. This ability, in turn, offers added information to physicians and supports the precise detection and diagnosis of diseases. 3D medical imaging provides advanced visualisation options and tools to radiologists and surgeons.
While market prospects appear promising, the major opportunities are likely to be restricted to large hospitals. The high price involved in large, enterprise-wide deployment, coupled with the lack of reimbursement for 3D imaging, which is not recognised as a separate procedure and is bundled with other diagnostic procedures, will challenge market participants.
"In Europe, very limited reimbursement is offered for performing imaging procedures using 3D visualisation," elaborates De. "Where reimbursement is offered, the 3D processing is typically not recognised as a distinct procedure, but is usually bundled with reimbursement for a particular modality procedure."
Despite the ease of viewing 3D rendered images, it requires highly skilled radiologists to pre-process the images. Moreover, the imaging tool can be effectively utilised only in hospitals which generate large volumes of data everyday.
To leverage growth opportunities, sales and marketing need to continuously minimise costs through efficient functioning, while R&D has to focus on reducing product development and manufacturing costs. Market participants need to produce user-friendly solutions with high levels of customer support, including training, maintenance and installation services. Partnering with PACS vendors also affords 3D visualisation companies expanded access to end users through the superior sales and distribution channels of PACS vendors.
European 3D Imaging Markets is part of the Medical Imaging Growth Partnership Service programme, which also includes research in the following markets: European Computed Tomography (CT) Systems Markets, European 3D Imaging Markets, European Molecular Imaging Markets, European Mobile Imaging Services Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.
Medicale de imagini 3D solutii de accesibilitate în creºtere în Europa - 3D Medical Imaging Solutions Growing In Affordability In Europe - articole medicale engleza - startsanatate